Anti-PEG Antibodies From mRNA COVID-19 Vaccines Affect In Vitro Measurements of Pegylated Drug Levels.
- DOI
- 10.1111/cts.70667
- Published
- 2026 Aug
- Container
- Clinical and translational science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cts.70667,
title = {Anti-PEG Antibodies From mRNA COVID-19 Vaccines Affect In Vitro Measurements of Pegylated Drug Levels.},
author = {Svyatova EA and Liu Z and Becker RE and Sung JM and Fayomi AP and Florian JA and Weaver JL and Rouse R and Howard KE},
year = {2026},
journal = {Clinical and translational science},
doi = {10.1111/cts.70667},
url = {https://doi.org/10.1111/cts.70667}
}RIS
TY - JOUR TI - Anti-PEG Antibodies From mRNA COVID-19 Vaccines Affect In Vitro Measurements of Pegylated Drug Levels. AU - Svyatova EA AU - Liu Z AU - Becker RE AU - Sung JM AU - Fayomi AP AU - Florian JA AU - Weaver JL AU - Rouse R AU - Howard KE PY - 2026 JO - Clinical and translational science DO - 10.1111/cts.70667 UR - https://doi.org/10.1111/cts.70667 ER -
APA
EA, S., Z, L., RE, B., JM, S., AP, F., JA, F., JL, W., R, R., & KE, H. (2026). Anti-PEG Antibodies From mRNA COVID-19 Vaccines Affect In Vitro Measurements of Pegylated Drug Levels.. Clinical and translational science. https://doi.org/10.1111/cts.70667
Source records
- pubmed · retrieved 2026-11-10T09:04:59.007Z